KIT and myeloid leukemia: Potential response markers were deduced from the correlation analysis of cell viabilities grouped according to diagnostic parameters including gene mutation status, peripheral blood and bone marrow blast cells percentage, and CD markers for the initial evaluation of myeloid leukemias including CD11b, CD34, and CD117 (c-KIT).